Dacomitinib (trade name Vizimpro) is a drug candidate under development by Pfizer for the treatment of non-small-cell lung carcinoma (NSCLC). It is a selective and irreversible inhibitor of EGFR. Reference standards of Dacomitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Dacomitinib - API Standards [catalogue_number] => PA 04 2190000 [category_ids] => ,78,75,70,76,82, [chemical_name] => [weight] => 469.95 [form] => C24H25ClFN5O2 [cas] => 1110813-31-4 [pslug] => 1110813-31-4-dacomitinib-api-pa042190000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 2190000
CAS :
Molecular Formula : C24H25ClFN5O2
Molecular Weight : 469.95
stdClass Object ( [pname] => 1-(4-((3-Chloro-4-fluorocyclohexyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one [catalogue_number] => PA 04 2191000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 402.81 [form] => C19H16ClFN4O3 [cas] => 2190490-31-2 [pslug] => 2190490-31-2-1-4-3-chloro-4-fluorocyclohexyl-amino-7-methoxyquinazolin-6-yl-5-hydroxypyrrolidin-2-one-pa042191000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 2191000
Molecular Formula : C19H16ClFN4O3
Molecular Weight : 402.81
stdClass Object ( [pname] => Dacomitinib Desmethyl Impurity [catalogue_number] => PA 04 2191001 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 455.92 [form] => C23H23ClFN5O2 [cas] => 2468202-15-3 [pslug] => 2468202-15-3-dacomitinib-desmethyl-impurity-pa042191001 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 2191001
Molecular Formula : C23H23ClFN5O2
Molecular Weight : 455.92
stdClass Object ( [pname] => Dacomitinib Z-Isomer [catalogue_number] => PA 04 2191002 [category_ids] => ,78,75,70,76,82, [chemical_name] => [weight] => 469.95 [form] => C24H25ClFN5O2 [cas] => NA [pslug] => dacomitinib-z-isomer-pa042191002 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 2191002
stdClass Object ( [pname] => (E)-N-(4-((3-Chloro-4-fluorophenyl)(nitroso)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide [catalogue_number] => PA 04 2191003 [category_ids] => ,78,75,70,76,82,162, [chemical_name] => [weight] => 498.94 [form] => C24H24ClFN6O3 [cas] => NA [pslug] => e-n-4-3-chloro-4-fluorophenyl-nitroso-amino-7-methoxyquinazolin-6-yl-4-piperidin-1-yl-but-2-enamide-pa042191003 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 04 2191003
Molecular Formula : C24H24ClFN6O3
Molecular Weight : 498.94
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
